Skip to main content
Caplight Logo









Breathe BioMedical

Breathe BioMedical

Private
Moncton, New BrunswickHealthcare & Life Scienceshttps://breathebiomedical.com/

Last Round

IPO

Oct 28, 2024

Total Funding Raised

$1.02M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Breathe BioMedical is a medical technology company that is developing a breath analytics platform for the early detection of diseases, with an initial focus on breast cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

breast cancer detectionbreath testbreath analyticsnon-invasive diagnosticsliquid biopsyearly disease detectionbreath biopsymedtechmedical AIbiomarker detectionmachine learning diagnosticssoftware as a medical deviceSaMDdense breast screeningadjunctive screeningbreath samplerspectrometry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Breathe BioMedical Comparables

Compare Breathe BioMedical with similar companies based on industry and business-model similarity.

Breathe BioMedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Menssana Research Inc.
78%
Owlstone Medical
77%
Breath Diagnostics
76%

Breathe BioMedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOOct 28, 2024
VC RoundJun 9, 2022
VC RoundJun 9, 2022
GrantFeb 4, 2022
GrantMay 29, 2019
Grant
Feb 12, 2019

Key People

Founding team and executive leadership

Bill Dawes

Chief Executive Officer

Executive Team

Christopher Purves

CTO

Executive Team

Breathe BioMedical Investors

Notable investors and investment history

Breathe BioMedical investors
InvestorRounds
New Brunswick Innovation FoundationVC Round, Grant
Atlantic Canada Opportunities AgencyVC Round, Grant
Maxim GroupIPO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 8, 2026

    Open roles increased to 39, 139% of headcount.

  • Jul 20, 2026

    Open roles increased to 39, 139% of current headcount.

Breathe BioMedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Breathe BioMedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Breathe BioMedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMoncton, New Brunswick
Employee Range27
Year Founded2005
Last FundingOct 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?